$RARE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Ultragenyx Pharmaceutical Inc.. Get notifications about new insider transactions in Ultragenyx Pharmaceutical Inc. for free.

Page: < prev 1 2 3 4 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	54.93	346	19,006	67,246	67.6 K to 67.2 K (-0.51 %)
May 29 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	57.18	433	24,759	15,985	16.4 K to 16 K (-2.64 %)
May 22 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	59.50	156	9,282	16,418	16.6 K to 16.4 K (-0.94 %)
May 22 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	59.50	1,414	84,133	468,806	470.2 K to 468.8 K (-0.30 %)
May 22 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	59.50	381	22,670	90,587	91 K to 90.6 K (-0.42 %)
May 22 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	59.50	381	22,670	67,592	68 K to 67.6 K (-0.56 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	1,434	0	67,973	66.5 K to 68 K (+2.16 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	1,434	0	38,613	37.2 K to 38.6 K (+3.86 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	1,434	0	21,014	19.6 K to 21 K (+7.32 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	3,435	0	470,220	466.8 K to 470.2 K (+0.74 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	1,438	0	24,802	23.4 K to 24.8 K (+6.15 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Grant	A	0.00	800	0	16,574	15.8 K to 16.6 K (+5.07 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	1,434	0	90,968	89.5 K to 91 K (+1.60 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	1,434	0	22,405	21 K to 22.4 K (+6.84 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	67.99	649	44,126	20,971	21.6 K to 21 K (-3.00 %)
Apr 30 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	68.30	468	31,964	19,580	20 K to 19.6 K (-2.33 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	64.43	798	51,415	466,785	467.6 K to 466.8 K (-0.17 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	64.43	138	8,891	15,504	15.6 K to 15.5 K (-0.88 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	64.43	248	15,979	21,445	21.7 K to 21.4 K (-1.14 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	64.43	248	15,979	36,718	37 K to 36.7 K (-0.67 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	64.43	248	15,979	20,048	20.3 K to 20 K (-1.22 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	64.43	248	15,979	66,078	66.3 K to 66.1 K (-0.37 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	64.43	248	15,979	89,226	89.5 K to 89.2 K (-0.28 %)
Mar 20 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	6.86	12,000	82,320	27,878
Mar 20 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	70.00	14,800	1,036,000	66,357	81.2 K to 66.4 K (-18.24 %)
Mar 20 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	6.86	12,000	82,320	81,157	69.2 K to 81.2 K (+17.35 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Option Exercise	A	67.55	20,000	1,351,000	20,000
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	67.55	607	41,003	21,711	22.3 K to 21.7 K (-2.72 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	6,000	0	22,318	16.3 K to 22.3 K (+36.77 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	67.55	23,000	1,553,650	23,000
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	67.55	701	47,353	36,986	37.7 K to 37 K (-1.86 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	20,000	0	37,687	17.7 K to 37.7 K (+113.08 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Hogenhuis Wladimir	Chief Operating Off ...	Option Exercise	A	67.55	11,000	743,050	11,000
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Hogenhuis Wladimir	Chief Operating Off ...	Grant	A	0.00	5,000	0	20,000	15 K to 20 K (+33.33 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	67.55	21,500	1,452,325	21,500
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	67.55	806	54,445	89,499	90.3 K to 89.5 K (-0.89 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	7,000	0	90,305	83.3 K to 90.3 K (+8.40 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	A	67.55	23,000	1,553,650	23,000
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	67.55	981	66,267	69,156	70.1 K to 69.2 K (-1.40 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	8,000	0	70,137	62.1 K to 70.1 K (+12.87 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Option Exercise	A	67.55	66,000	4,458,300	66,000
Mar 04 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	67.55	2,802	189,275	467,670	470.5 K to 467.7 K (-0.60 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	20,000	0	470,472	450.5 K to 470.5 K (+4.44 %)
Feb 15 2019	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	48.85	1,636	79,919	16,364	18 K to 16.4 K (-9.09 %)
Feb 01 2019	RARE	Ultragenyx Pharmac ...	SULIMAN SHEHNAAZ	Director	Option Exercise	A	48.85	20,000	977,000	20,000
Jan 02 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Option Exercise	M	21.00	2,448	51,408	17,000
Jan 02 2019	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Buy	M	21.00	2,448	51,408	14,505	12.1 K to 14.5 K (+20.30 %)
Dec 07 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	49.69	6,000	298,140	90,350	96.4 K to 90.4 K (-6.23 %)
Nov 08 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	55.67	6,000	334,020	96,350	102.4 K to 96.4 K (-5.86 %)
Oct 31 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	12,000	9,780	6,963
Oct 31 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	12,000	9,780	62,128	50.1 K to 62.1 K (+23.94 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	C	0.00	266,343	0	0
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	73.38	6,000	440,280	102,350	108.4 K to 102.4 K (-5.54 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	53.97	650	35,081	108,350	109 K to 108.4 K (-0.60 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	122.58	400	49,032	109,000	109.4 K to 109 K (-0.37 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	85.94	2,000	171,880	109,400	111.4 K to 109.4 K (-1.80 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	68.65	10,500	720,825	111,400	121.9 K to 111.4 K (-8.61 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	C	0.00	84,970	0	121,900	36.9 K to 121.9 K (+230.08 %)
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Hogenhuis Wladimir	Chief Operating Off ...	Option Exercise	A	77.30	75,000	5,797,500	75,000
Oct 09 2018	RARE	Ultragenyx Pharmac ...	Hogenhuis Wladimir	Chief Operating Off ...	Grant	A	0.00	15,000	0	15,000	0 to 15 K
Sep 27 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	3,350	2,730	18,963
Sep 27 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	90.07	6,700	603,469	50,128	56.8 K to 50.1 K (-11.79 %)
Sep 27 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	3,350	2,730	56,828	53.5 K to 56.8 K (+6.26 %)
Aug 21 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	78.53	5,000	392,650	9,181	14.2 K to 9.2 K (-35.26 %)
Aug 08 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Sell	S	76.66	3,750	287,475	72,610	76.4 K to 72.6 K (-4.91 %)
Jul 16 2018	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	84.35	649	54,743	17,681	18.3 K to 17.7 K (-3.54 %)
Jun 21 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	82.77	1,226	101,476	14,181	15.4 K to 14.2 K (-7.96 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Payment of Exercise	F	85.31	649	55,366	15,407	16.1 K to 15.4 K (-4.04 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Dunsire Deborah	Director	Grant	A	0.00	3,000	0	4,875	1.9 K to 4.9 K (+160.00 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Grant	A	0.00	3,000	0	6,750	3.8 K to 6.8 K (+80.00 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Grant	A	0.00	3,000	0	6,750	3.8 K to 6.8 K (+80.00 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	3,000	0	11,750	8.8 K to 11.8 K (+34.29 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Ekman Lars	Director	Grant	A	0.00	3,000	0	6,750	3.8 K to 6.8 K (+80.00 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Grant	A	0.00	3,000	0	76,360	73.4 K to 76.4 K (+4.09 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Grant	A	0.00	3,000	0	6,750	3.8 K to 6.8 K (+80.00 %)
Jun 15 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Option Exercise	M	21.00	2,955	62,055	19,448
Jun 15 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Sell	S	83.70	955	79,934	11,940	12.9 K to 11.9 K (-7.41 %)
Jun 15 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Buy	M	21.00	2,955	62,055	12,895	9.9 K to 12.9 K (+29.73 %)
Jun 15 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Option Exercise	M	21.00	2,955	62,055	19,448
Jun 15 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Sell	S	83.70	955	79,934	11,940	12.9 K to 11.9 K (-7.41 %)
Jun 15 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Buy	M	21.00	2,955	62,055	12,895	9.9 K to 12.9 K (+29.73 %)
Jun 13 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Sell	S	76.97	1,338	102,986	9,940	11.3 K to 9.9 K (-11.86 %)
Jun 07 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	3,350	2,730	22,313
Jun 07 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	80.07	6,700	536,456	53,478	60.2 K to 53.5 K (-11.13 %)
Jun 07 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	3,350	2,730	60,178	56.8 K to 60.2 K (+5.89 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	73.73	346	25,511	56,828	57.2 K to 56.8 K (-0.61 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	73.73	260	19,170	16,124	16.4 K to 16.1 K (-1.59 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Payment of Exercise	F	73.73	294	21,677	23,830	24.1 K to 23.8 K (-1.22 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	73.73	346	25,511	83,114	83.5 K to 83.1 K (-0.41 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	73.73	926	68,274	450,472	451.4 K to 450.5 K (-0.21 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	73.73	260	19,170	18,330	18.6 K to 18.3 K (-1.40 %)
May 30 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	M	0.82	6,500	5,298	25,663
May 30 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Sell	S	70.17	13,000	912,171	57,174	70.2 K to 57.2 K (-18.53 %)
May 30 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Buy	M	0.82	6,500	5,298	70,174	63.7 K to 70.2 K (+10.21 %)
May 30 2018	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	72.00	6,319	454,969	8,750	15.1 K to 8.8 K (-41.93 %)
May 29 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	67.31	433	29,145	11,278	11.7 K to 11.3 K (-3.70 %)
May 22 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	64.79	381	24,685	63,674	64.1 K to 63.7 K (-0.59 %)
May 22 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	64.79	381	24,685	83,460	83.8 K to 83.5 K (-0.45 %)
May 22 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	64.79	156	10,107	11,711	11.9 K to 11.7 K (-1.31 %)
May 22 2018	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Payment of Exercise	F	64.79	986	63,883	451,398	452.4 K to 451.4 K (-0.22 %)
May 10 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Sell	S	60.00	1,465	87,900	16,056	17.5 K to 16.1 K (-8.36 %)
May 08 2018	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	54.50	649	35,371	16,384	17 K to 16.4 K (-3.81 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Grant	A	0.00	799	0	11,474	10.7 K to 11.5 K (+7.48 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Parschauer Karah Herdman	EVP and General Cou ...	Grant	A	0.00	1,431	0	17,521	16.1 K to 17.5 K (+8.89 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	1,431	0	18,076	16.6 K to 18.1 K (+8.60 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	1,431	0	16,850	15.4 K to 16.9 K (+9.28 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Grant	A	0.00	1,431	0	23,604	22.2 K to 23.6 K (+6.45 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	1,431	0	83,529	82.1 K to 83.5 K (+1.74 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	1,431	0	63,544	62.1 K to 63.5 K (+2.30 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Grant	A	0.00	3,429	0	452,384	449 K to 452.4 K (+0.76 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Option Exercise	A	48.43	7,975	386,229	7,975
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Payment of Exercise	F	48.43	110	5,327	10,675	10.8 K to 10.7 K (-1.02 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Huizenga Theodore Alan	VP, Controller and ...	Grant	A	0.00	1,313	0	10,785	9.5 K to 10.8 K (+13.86 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Option Exercise	A	48.43	25,000	1,210,750	25,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Payment of Exercise	F	48.43	205	9,928	15,419	15.6 K to 15.4 K (-1.31 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Huang Dennis Karl	EVP & Chief Tech Op ...	Grant	A	0.00	4,500	0	15,624	11.1 K to 15.6 K (+40.45 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Option Exercise	A	48.43	27,000	1,307,610	27,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	48.43	276	13,367	16,645	16.9 K to 16.6 K (-1.63 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Grant	A	0.00	5,000	0	16,921	11.9 K to 16.9 K (+41.94 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Option Exercise	A	48.43	32,000	1,549,760	32,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Payment of Exercise	F	48.43	441	21,358	22,173	22.6 K to 22.2 K (-1.95 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Grant	A	0.00	6,500	0	22,614	16.1 K to 22.6 K (+40.34 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	48.43	30,000	1,452,900	30,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	48.43	307	14,868	82,098	82.4 K to 82.1 K (-0.37 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	6,000	0	82,405	76.4 K to 82.4 K (+7.85 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Option Exercise	A	48.43	35,000	1,695,050	35,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Payment of Exercise	F	48.43	397	19,227	62,113	62.5 K to 62.1 K (-0.64 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Sharp Shalini	CFO & Executive Vic ...	Grant	A	0.00	7,000	0	62,510	55.5 K to 62.5 K (+12.61 %)
Jan 31 2018	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	A	55.00	88,000	4,840,000	88,000
Jan 31 2018	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	18,000	0	18,000	0 to 18 K
Jan 25 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Option Exercise	M	21.00	11,500	241,500	0
Jan 25 2018	RARE	Ultragenyx Pharmac ...	Aliski William	Director	Buy	M	21.00	11,500	241,500	73,360	61.9 K to 73.4 K (+18.59 %)
Aug 29 2017	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Buy	P	52.96	1,647	87,225	2,559,741	2.6 M to 2.6 M (+0.06 %)
Aug 29 2017	RARE	Ultragenyx Pharmac ...	KAKKIS EMIL D	President & CEO	Buy	P	52.40	5,853	306,697	2,558,094	2.6 M to 2.6 M (+0.23 %)
Aug 07 2017	RARE	Ultragenyx Pharmac ...	Dallas Jayson Donald Alexander	EVP & Chief Commerc ...	Payment of Exercise	F	62.59	940	58,835	16,107	17 K to 16.1 K (-5.51 %)
Jul 17 2017	RARE	Ultragenyx Pharmac ...	Pinion John Richard	See Remarks	Payment of Exercise	F	64.36	705	45,374	11,883	12.6 K to 11.9 K (-5.60 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	WELCH DANIEL G	Director	Grant	A	0.00	1,875	0	3,750	1.9 K to 3.8 K (+100.00 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	SIEGALL CLAY B	Director	Grant	A	0.00	1,875	0	3,750	1.9 K to 3.8 K (+100.00 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	NARACHI MICHAEL	Director	Grant	A	0.00	1,875	0	3,750	1.9 K to 3.8 K (+100.00 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	65.66	3,750	246,225	3,750

Page: < prev 1 2 3 4 5 next >